We are live on ! Find out more
VERA icon

Vera Therapeutics
VERA

55 hedge funds and large institutions have $459M invested in Vera Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

66% more capital invested

Capital invested by funds: $276M → $459M (+$183M)

8% more funds holding

Funds holding: 51 → 55 (+4)

3.47% more ownership

Funds ownership: 76.19% → 79.66% (+3.5%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
55
Holders Change
+4
Holders Change %
+7.84%
% of All Funds
0.95%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
7
Increased
25
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IBT
International Biotechnology Trust
United Kingdom
+$5.19M
2
PAMP
Polar Asset Management Partners
Ontario, Canada
+$4.29M
3
WP
Woodline Partners
California
+$3.17M
4
EP
Eversept Partners
New York
+$2.92M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.27M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.46M
2
OCA
Octagon Capital Advisors
New York
-$781K
3
JP Morgan Chase
JP Morgan Chase
New York
-$442K
4
Citigroup
Citigroup
New York
-$187K
5
DTL
Dynamic Technology Lab
Singapore
-$162K
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
26
Swiss National Bank
Switzerland
$739K – – –
Bank of America
27
Bank of America
North Carolina
$733K +$242K +12,943 +60%
Morgan Stanley
28
Morgan Stanley
New York
$489K +$365K +19,495 +563%
Ensign Peak Advisors
29
Ensign Peak Advisors
Utah
$450K +$147K +7,839 +59%
GTCM
30
Gyon Technologies Capital Management
New Jersey
$435K +$382K +20,431 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$391K -$4.1K -219 -1%
RJFSA
32
Raymond James Financial Services Advisors
Florida
$380K – – –
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$375K +$24.9K +1,328 +8%
CMU
34
Carnegie Mellon University
Pennsylvania
$342K – – –
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$321K +$282K +15,051 New
AA
36
ALPS Advisors
Colorado
$314K -$24.6K -1,316 -8%
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$235K +$636 +34 +0.3%
Barclays
38
Barclays
United Kingdom
$214K +$175K +9,329 +1,340%
CT
39
Cambridge Trust
Massachusetts
$211K – – –
CS
40
Credit Suisse
Switzerland
$207K +$1.18K +63 +0.7%
MIM
41
MetLife Investment Management
New Jersey
$189K – – –
AIG
42
American International Group
New York
$142K +$3.05K +163 +3%
Deutsche Bank
43
Deutsche Bank
Germany
$133K -$43.4K -2,317 -27%
Legal & General Group
44
Legal & General Group
United Kingdom
$114K +$9.14K +488 +10%
UBS Group
45
UBS Group
Switzerland
$113K +$91.8K +4,903 +1,241%
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$110K +$97K +5,183 New
CSS
47
Cubist Systematic Strategies
Connecticut
$107K +$93.6K +5,000 New
AB
48
Amalgamated Bank
New York
$47K +$861 +46 +2%
SO
49
STRS Ohio
Ohio
$34K – – –
TRCT
50
Tower Research Capital (TRC)
New York
$33K +$1.97K +105 +7%
1
2
3

VERA Hedge Fund Activity: Q3 2022 in Review

55 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Vera Therapeutics (VERA) for Q3 2022, worth a combined $459M — up 66% from $276M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new VERA positions and 3 closed out — a net gain of 4 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was International Biotechnology Trust, adding an estimated $5.19M. The largest seller was Citadel Advisors, cutting an estimated $2.46M.

  • 55 institutional investors held Vera Therapeutics (VERA) as of Q3 2022, up from 51 in Q2 2022.
  • Funds reported $459M of Vera Therapeutics stock for Q3 2022, up 66% quarter-over-quarter.
  • 7 funds opened new Vera Therapeutics positions in Q3 2022 and 3 closed out, a net change of +4 holders.
  • The largest Vera Therapeutics buyer in Q3 2022 was International Biotechnology Trust, an estimated $5.19M added.
  • The largest Vera Therapeutics seller in Q3 2022 was Citadel Advisors, an estimated $2.46M sold.

Based on aggregated 13F filings for Q3 2022.